Company description
The ongoing outbreak of the recently emerged novel coronavirus (SARS-CoV-2) poses a challenge for public health. Molecular diagnostic tools are in urgent need to help rapidly identify this novel CoV. As a well-known CRO company serving both the therapeutic and diagnostic industry, Creative Biolabs offers custom assay design, development, and manufacturing service to improve SARS-CoV-2 infection detection.
